Buradasınız

Anasayfa » Content

DEHYDROEPIANDROSTERONE LEVELS AND COGNITIVE FUNCTION IN AGING

DEHYDROEPIANDROSTERONE LEVELS AND COGNITIVE FUNCTION IN AGING

Journal Name:

  • International Journal of Medical Research & Health Sciences

Publication Year:

  • 2013

Key Words:

Author Name
Abstract (2. Language): 
Background: Dehydroepiandrosterone (DHEA) is a steroid hormone secreted by the adrenal cortex. Recent research reports show that DHEA has various beneficial effects including neuro protective effects and that the decline in its production with aging may contribute to neuronal dysfunction and degeneration, and thus cognitive decline.Aim: To assess the cognitive functions and estimate the levels of DHEA in subjects of the same age group. Materials and Methods: A cross sectional comparative study of sixty healthy male participants between 60 to 70 years of age was done. They did not have other medical disorders likely to affect cognitive function. Their performance in the principal domains of cognition, i.e. memory, attention and concentration, verbal fluency, language and visuospatial functioning was observed. Serum levels of DHEA were estimated for all the participants by ELISA method. Results: A significant positive correlation was observed between DHEA level and three domains of cognition viz., visuospatial skills (r = 0.95), verbal fluency (r = 0.49) and short term memory (r = 0.28). No association was found with other domains of cognition. Conclusion: Subjects with low levels of serum DHEA among the same age group showed a significant decline in visuospatial skills, short term memory and verbal fluency.
Bookmark/Search this post with
FULL TEXT (PDF): 
PDF icon arastirmax-dehydroepiandrosterone-levels-and-cognitive-function-aging.pdf
  • 1
101-106
  • Turkish

REFERENCES

References: 

1. Adams JB. Control of secretion and function
of C19-delta 5-steroids of the human adrenal
gland. Mol Cell Endocrinol 1985; 41:1–17.
2. Roberts E, Bologa L, Flood JF, Smith GE.
Effects of dehydroepiandrosterone and its
sulfate on brain tissue in culture and on
memory in mice. Brain Res. 1978; 406:357–
62.
3. Bologa L, Sharma J, Roberts E. 1987
Dehydroepiandrosterone, and its sulfated
derivative reduce neuronal death and enhance
astrocytic differentiation in brain cell cultures.
J Neurosci Res.1987; 17:225–34
4. Wolkowitz, Owen M., et al.
Dehydroepiandrosterone (DHEA) treatment of
depression. Biological Psychiatry.1997; 41(3):
311-18.
5. Debonnel G, Bergeron R, and de Montigny C.
Potentiation by dehydroepiandrosterone of the
neuronal response to N-methyl-D-aspartate in
the CA3 region of the rat dorsal hippocampus:
105
Rathna et al., Int J Med res Health Sci. 2013; 2(1):101-106
an effect mediated via sigma receptors.
Journal of Endocrinology 1996;150:S33-42.
6. Kimonides VG, Khatibi NH, Svendsen CN,
Sofroniew MV, Herbert J.
Dehydroepiandrosterone (DHEA) and DHEAsulfate
(DHEAS) protect hippocampal
neurons against excitatory amino acid-induced
neurotoxicity. Proceedings of the National
Academy of Sciences USA 1998; 95:1852-57.
7. Blauer KL, Poth M, Rogers WM, Bernton
EW. Dehydroepiandrosterone antagonises the
suppressive effects of dexamethasone on
lymphocyte proliferation. Endocrinology
1991; 129:3174-79.
8. Lupien SJ, de Leon M, de Santi S, Convit A,
Tarshish C, Nair NPV. Cortisol levels during
human aging predict hippocampal atrophy and
memory deficits. Nature Neuroscience 1998;
1(1):69-73.
9. Herbert J. Stress, the brain, and mental illness.
BMJ 1997; 315:530-35.
10. Hillen T, Lun A, Reischies FM, Borchelt M,
Steinhagen TE, Schaub RT. DHEA-S plasma
levels and incidence of Alzheimer's disease.
Biological Psychiatry 2000; 47(2):161-163.
11. Baulieu EE, Robel P. Dehydroepiandrosterone
and dehydroepiandrosterone Sulfate as
neuroactive neurosteroids. J Endocrinol 1996;
150:S221–39
12. Bergeron R, Montigny CD, Debonnel G.
Potentiation of neuronal NMDA response
induced by dehydroepiandrosterone and its
suppression by progesterone: effects mediated
by sigma receptors. J Neurosci 1996;
16(3):1193–202.
13. Wolf OT, Neumann O, Hellhammer DH,
Geiben AC, Strasburger CJ, Dressendorfer
RA, et al. Effects of a 2-week physiological
dehydroepiandrosterone substitution on
cognitive performance and well-being in
healthy elderly women and men. J Clin
Endocrinol Metab 1997; 82(7):2363–67.
14. Hillen, Thomas, et al. DHEA-S plasma levels
and incidence of Alzheimer’s disease.
Biological psychiatry.2000; 47(2): 161-63.
15. Davis SR, Shah S, McKenzie D, Kulkarni J,
Davison S, Bell R. Dehydroepiandrosterone
Sulfate Levels Are Associated with More
Favorable Cognitive Function in Women.
Clinical Endocrinology and Metabolism 2008;
93(3):801–08.
16. Mioshi, Eneida, et al. The Addenbrooke's
Cognitive Examination Revised (ACE‐R): a
brief cognitive test battery for dementia
screening. International journal of geriatric
psychiatry. 2006; 21(11): 1078-85.

Thank you for copying data from http://www.arastirmax.com